![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: EEPD1 |
Gene summary for EEPD1 |
![]() |
Gene information | Species | Human | Gene symbol | EEPD1 | Gene ID | 80820 |
Gene name | endonuclease/exonuclease/phosphatase family domain containing 1 | |
Gene Alias | HSPC107 | |
Cytomap | 7p14.2 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q7L9B9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
80820 | EEPD1 | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.88e-02 | -2.29e-01 | 0.0155 |
80820 | EEPD1 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.01e-06 | 5.35e-01 | -0.0811 |
80820 | EEPD1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.76e-02 | 4.38e-01 | -0.059 |
80820 | EEPD1 | HTA11_7696_3000711011 | Human | Colorectum | AD | 8.51e-05 | 4.18e-01 | 0.0674 |
80820 | EEPD1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 3.97e-17 | 9.03e-01 | 0.3859 |
80820 | EEPD1 | A015-C-203 | Human | Colorectum | FAP | 3.80e-10 | 2.73e-03 | -0.1294 |
80820 | EEPD1 | A002-C-201 | Human | Colorectum | FAP | 7.08e-03 | -6.67e-02 | 0.0324 |
80820 | EEPD1 | A002-C-203 | Human | Colorectum | FAP | 1.71e-03 | 3.35e-01 | 0.2786 |
80820 | EEPD1 | A001-C-108 | Human | Colorectum | FAP | 1.34e-07 | 1.94e-01 | -0.0272 |
80820 | EEPD1 | A002-C-205 | Human | Colorectum | FAP | 3.81e-07 | -5.74e-02 | -0.1236 |
80820 | EEPD1 | A001-C-104 | Human | Colorectum | FAP | 3.07e-04 | 2.95e-01 | 0.0184 |
80820 | EEPD1 | A015-C-006 | Human | Colorectum | FAP | 1.35e-02 | -1.60e-01 | -0.0994 |
80820 | EEPD1 | A015-C-106 | Human | Colorectum | FAP | 8.10e-05 | 1.36e-01 | -0.0511 |
80820 | EEPD1 | A002-C-114 | Human | Colorectum | FAP | 1.99e-05 | -1.58e-01 | -0.1561 |
80820 | EEPD1 | A015-C-104 | Human | Colorectum | FAP | 1.27e-11 | -1.02e-01 | -0.1899 |
80820 | EEPD1 | A001-C-014 | Human | Colorectum | FAP | 2.49e-04 | 1.45e-01 | 0.0135 |
80820 | EEPD1 | A002-C-016 | Human | Colorectum | FAP | 7.95e-07 | -9.54e-02 | 0.0521 |
80820 | EEPD1 | A015-C-002 | Human | Colorectum | FAP | 1.35e-02 | -6.86e-02 | -0.0763 |
80820 | EEPD1 | A001-C-203 | Human | Colorectum | FAP | 1.26e-03 | 1.93e-01 | -0.0481 |
80820 | EEPD1 | A002-C-116 | Human | Colorectum | FAP | 3.08e-14 | -2.57e-01 | -0.0452 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0010876 | Colorectum | AD | lipid localization | 120/3918 | 448/18723 | 1.59e-03 | 1.33e-02 | 120 |
GO:0006869 | Colorectum | AD | lipid transport | 108/3918 | 398/18723 | 1.67e-03 | 1.39e-02 | 108 |
GO:00108761 | Colorectum | MSS | lipid localization | 104/3467 | 448/18723 | 6.76e-03 | 4.38e-02 | 104 |
GO:00068691 | Colorectum | FAP | lipid transport | 81/2622 | 398/18723 | 2.84e-04 | 3.76e-03 | 81 |
GO:00108762 | Colorectum | FAP | lipid localization | 85/2622 | 448/18723 | 1.92e-03 | 1.63e-02 | 85 |
GO:00068692 | Colorectum | CRC | lipid transport | 63/2078 | 398/18723 | 2.36e-03 | 2.26e-02 | 63 |
GO:00108763 | Colorectum | CRC | lipid localization | 68/2078 | 448/18723 | 4.60e-03 | 3.58e-02 | 68 |
GO:00108765 | Liver | NAFLD | lipid localization | 79/1882 | 448/18723 | 4.75e-07 | 2.92e-05 | 79 |
GO:00303013 | Liver | NAFLD | cholesterol transport | 30/1882 | 117/18723 | 1.08e-06 | 5.40e-05 | 30 |
GO:00068694 | Liver | NAFLD | lipid transport | 71/1882 | 398/18723 | 1.16e-06 | 5.59e-05 | 71 |
GO:00159183 | Liver | NAFLD | sterol transport | 32/1882 | 130/18723 | 1.27e-06 | 6.01e-05 | 32 |
GO:0032373 | Liver | NAFLD | positive regulation of sterol transport | 15/1882 | 38/18723 | 1.68e-06 | 7.43e-05 | 15 |
GO:0032376 | Liver | NAFLD | positive regulation of cholesterol transport | 15/1882 | 38/18723 | 1.68e-06 | 7.43e-05 | 15 |
GO:0033344 | Liver | NAFLD | cholesterol efflux | 20/1882 | 69/18723 | 9.13e-06 | 2.98e-04 | 20 |
GO:0015850 | Liver | NAFLD | organic hydroxy compound transport | 50/1882 | 284/18723 | 6.01e-05 | 1.32e-03 | 50 |
GO:0032371 | Liver | NAFLD | regulation of sterol transport | 20/1882 | 78/18723 | 6.46e-05 | 1.39e-03 | 20 |
GO:0032374 | Liver | NAFLD | regulation of cholesterol transport | 20/1882 | 78/18723 | 6.46e-05 | 1.39e-03 | 20 |
GO:0010875 | Liver | NAFLD | positive regulation of cholesterol efflux | 10/1882 | 26/18723 | 1.20e-04 | 2.32e-03 | 10 |
GO:1905952 | Liver | NAFLD | regulation of lipid localization | 34/1882 | 181/18723 | 2.51e-04 | 4.12e-03 | 34 |
GO:1905954 | Liver | NAFLD | positive regulation of lipid localization | 23/1882 | 110/18723 | 5.16e-04 | 7.15e-03 | 23 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EEPD1 | SNV | Missense_Mutation | c.862A>G | p.Thr288Ala | p.T288A | Q7L9B9 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
EEPD1 | SNV | Missense_Mutation | novel | c.1497N>T | p.Lys499Asn | p.K499N | Q7L9B9 | protein_coding | deleterious(0.02) | possibly_damaging(0.506) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
EEPD1 | SNV | Missense_Mutation | rs749463199 | c.1600N>T | p.Val534Leu | p.V534L | Q7L9B9 | protein_coding | deleterious(0.01) | probably_damaging(0.978) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
EEPD1 | SNV | Missense_Mutation | rs763941759 | c.556G>A | p.Ala186Thr | p.A186T | Q7L9B9 | protein_coding | tolerated(0.6) | benign(0.003) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
EEPD1 | SNV | Missense_Mutation | novel | c.953N>A | p.Pro318Gln | p.P318Q | Q7L9B9 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-BK-A13B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
EEPD1 | SNV | Missense_Mutation | novel | c.433N>A | p.Ala145Thr | p.A145T | Q7L9B9 | protein_coding | tolerated(0.6) | possibly_damaging(0.739) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
EEPD1 | SNV | Missense_Mutation | novel | c.371N>A | p.Pro124His | p.P124H | Q7L9B9 | protein_coding | tolerated(0.26) | possibly_damaging(0.541) | TCGA-EO-A22T-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
EEPD1 | SNV | Missense_Mutation | rs747815515 | c.178N>A | p.Val60Met | p.V60M | Q7L9B9 | protein_coding | deleterious(0) | possibly_damaging(0.865) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
EEPD1 | SNV | Missense_Mutation | novel | c.65G>A | p.Arg22His | p.R22H | Q7L9B9 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
EEPD1 | SNV | Missense_Mutation | rs759905183 | c.122N>G | p.Asn41Ser | p.N41S | Q7L9B9 | protein_coding | deleterious(0.01) | probably_damaging(0.998) | TCGA-SL-A6J9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |